Search results for: Anti-human Apolipoprotein-H (β2-Glycoprotein-I ) Antibody
#33625289 // To Up
Monoclonal Antibody JMAM-1 (Mouse Antihuman CD10) Against Malignant Mesothelioma.
1374 related Products with: Monoclonal Antibody JMAM-1 (Mouse Antihuman CD10) Against Malignant Mesothelioma.100ug100ul100ul100ul100ul100ug0.1 mg100ug Lyophilized100ug Lyophilized100ug Lyophilized100ug100ug Lyophilized
No related Items
Error loading info... Pleas try again later.
#33433412 // To Up
Glomerular C4d deposition in proliferative glomerular diseases.The aim of this study was to evaluate the immunohistochemical expression of C4d in native renal biopsies of proliferative glomerular diseases, complement pathways in these diseases, and assess the relationship of C4d with histological and clinicopathological parameters, other complement proteins, and immunoglobulin markers.
Sarojini Raman, Pallavi Mishra, Ansuman Panigrahi, Nikunj K Rout, Kanakalata Dash1.00 flask500 tests96 tests500 tests500 tests1.00 flask500 tests500 tests500 tests500 tests1.00 kit
#33374617 2020/12/23 To Up
Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection.Antibody-mediated allograft rejection (AMR) hinders patient prognosis after organ transplantation. Current studies concerning AMR have mainly focused on the diagnostic value of immunoglobulin G (IgG)-type donor-specific antihuman leukocyte antigen antibodies (DSAs), primarily because of their antigen specificity, whereas the clinical significance of immunoglobulin M (IgM)-type DSAs has not been thoroughly investigated in the context of organ transplantation because of their nonspecificity against antigens. Although consensus regarding the clinical significance and role of IgM antibodies is not clear, as discussed in this review, recent findings strongly suggest that they also have a huge potential in novel diagnostic as well as therapeutic application for the prevention of AMR. Most serum IgM antibodies are known to comprise natural antibodies with low affinity toward antigens, and this is derived from B-1 cells (innate B cells). However, some of the serum IgM-type antibodies reportedly also produced by B-2 cells (conventional B cells). The latter are known to have a high affinity for donor-specific antigens. In this review, we initially discuss how IgM-type antibodies of different origins participate in the pathology of various diseases, directly or through cell surface receptors, complement activation, or cytokine production. Then, we discuss the clinical applicability of B-1 and B-2 cell-derived IgM-type antibodies for controlling AMR with reference to the involvement of IgM antibodies in various pathological conditions.
Yoshiko Matsuda, Takahisa Hiramitsu, Xiao-Kang Li, Takeshi Watanabe
2312 related Products with: Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection.4 Arrays/Slide100ug Lyophilized4 Membranes/Box100 ug4 Membranes/Box4 Membranes/Box100 TESTS4 Membranes/Box4 Membranes/Box100ug Lyophilized
#33237536 // To Up
Phenotyping of Myeloid-Derived Suppressor Cells in Nonhuman Primates.W
Ang Lin, Karin Loré1x10e7 cells96 assays100 µg1 mg1.00 flask1.00 flask4 x 96-well plate1 mg10 ug1x10e7 cells96 tests
No related Items
#33210724 2020/10/30 To Up
Expression of trefoil factor 3 is decreased in colorectal cancer.In colorectal cancer (CRC), high expression of trefoil factor 3 (TFF3) is associated with tumor progression and reduced patient survival; however, bioinformatics analyses of public 'omics' databases show low TFF3 expression in CRCs as compared to normal tissues. Thus, we examined TFF3 expression in CRCs and matching normal tissues to evaluate its role in CRC progression. TFF3 gene expression was characterized using the bioinformatics portal UALCAN (http://ualcan.path.uab.edu). Tissue microarrays (TMAs) of archival CRC specimens (n=96) were immunostained with anti‑human TFF3 antibodies. Immunohistochemical (IHC) staining intensity was semi‑quantitatively scored. For this cohort, the median follow‑up was 5.4 years. Associations between clinical and pathological variables were determined using Chi‑square or Fisher's exact tests. Univariate disease‑free survival was estimated by the Kaplan‑Meier method. Omics data analyses by UALCAN showed downregulation of TFF3 expression in CRC relative to normal tissue at protein (χ2, P<0.0001) levels. There was a similar decreasing trend of TFF3 expression in the pathologic stages of the CRCs (RNA, χ2, P=0.88 and protein, χ2 P<0.0001). UALCAN data analysis showed that TFF3 exhibited 27% lower mRNA expression in tumors with mutant TP53 (P=0.007). Confirming the findings of omics analyses, IHC analysis of TMAs exhibited lower TFF3 expression in 95.6% (65 of 68) of the available normal‑tumor matching pairs (χ2, P<0.0001). There was no statistically significant association of tumor TFF3 expression with patient sex, race/ethnicity, tumor location within the colorectum, Tumor, Node, Metastasis (TNM) stage, lymph node metastasis, or surgical margins. However, low TFF3 IHC staining in tumor tissue was associated with histological grade (P=0.026). Kaplan‑Meier survival analysis showed no prognostic value of low TFF3 expression relative to those with high expression (log‑rank, P=0.605). Our findings demonstrate low expression of TFF3 in CRCs. Association between low TFF3 and histopathological features suggests involvement of this molecule in progression of CRC.
Ingrid Espinoza, Sumit Agarwal, Amit Reddy, Veena Shenoy, Charulochana Subramony, Marcelo Sakiyama, Logan Fair, Teja Poosarla, Xinchun Zhou, W Shannon Orr, Christopher Lahr, Sejong Bae, Sameer Al Diffalha, Upender Manne, Christian R Gomez0.1 mg0.1ml (1mg/ml)100 ul0.1 mg100ug Lyophilized100ug Lyophilized250 mg
#33175401 2020/11/23 To Up
Urgent desensitization in patients bridged to heart transplantation under extracorporeal membrane oxygenation support: A preliminary experience.Antihuman leukocyte antigen (HLA) antibodies restrict the access to cardiac allografts. Desensitization therapy is a major challenge in patients with cardiogenic shock waiting for urgent heart transplantation (HT). We retrospectively reviewed six patients (mean age of 37.5 years [16-70]) who underwent plasmapheresis (PP) under extracorporeal membrane oxygenation (ECMO) before transplant between January 2017 and September 2018. The average duration of follow-up was 25 months [20-32]. Mean fluorescence intensity (MFI) of HLA-specific antibodies was reported as follows: score 4 for MFI < 1000, score 6 for 1000 < MFI < 3000 and score 8 for MFI > 3000. The mean duration of ECMO support was 29 days [1-74] and 6.8 [1-29] PP sessions were performed per patient before transplant. The mean number of HLA-specific antibodies before HT was 9.6 for score 6 [4-13] and 5.8 for score 8 [1-12]. Four patients had major complications after transplantation (2 hemorrhagic shocks, 5 infectious events). Mean MFI reduction rate was 94% [79-100] for Class I and 44.2% for Class II [0-83]. Hospital survival was 100%, and early antibody-mediated rejection was diagnosed in one patient at 7 days after HT. Plasmapheresis under ECMO support was associated with favorable early outcomes in highly sensitized candidates for urgent heart transplantation.
Julien Guihaire, Serena D'Avino, Francois Stephan, Martin Kloeckner, Ngoc Tram To, Agathe Potier, Maïra Gaillard, Ramzi Ramadan, Jean-Luc Taupin, Jerome Le Pavec, Philippe Deleuze
1838 related Products with: Urgent desensitization in patients bridged to heart transplantation under extracorporeal membrane oxygenation support: A preliminary experience.4 Membranes/Box1 kit4 Membranes/Box4 Membranes/Box4 Membranes/Box4 Membranes/Box100 4 Membranes/Box4 Membranes/Box1 kit4 Membranes/Box
#33121367 2020/10/29 To Up
Highly Specific Mouse Anti-Joining Chain of Human Immunoglobulin A.I
Monir Ejemel, Melissa A Gawron, Matthew I Schneider, Aaron Wallace, Zachary A Schiller, Ryan Schneider, Joseph C Martin Iii, Mark S Klempner, Yang Wang, Lisa A Cavacini100.00 ug500 500 100 TESTS100ug Lyophilized1 mg1 mg1 mg500 1 mg100 Tests25 µg
No related Items
#32969848 // To Up
Efficacy of Rabbit Antithymocyte Globulin as a First-line Therapy in Children With Aplastic Anemia.The efficacy, safety, and outcome of rabbit antihuman thymocyte globulin (rATG) as initial therapy for children aplastic anemia (AA) were evaluated.
Fuxing Li, Wei He, Wei Shi, Xiaotian Xie
1300 related Products with: Efficacy of Rabbit Antithymocyte Globulin as a First-line Therapy in Children With Aplastic Anemia.1 mL1 mL100ug Lyophilized100ug Lyophilized100 assays100ug100ug100ug100ug Lyophilized100ug Lyophilized 100ul100ug Lyophilized
#32954173 2020/08/31 To Up
Highly Sensitive Fluorescence-Linked Immunosorbent Assay for the Determination of Human IgG in Serum Using Quantum Dot Nanobeads and Magnetic FeO Nanospheres.T
Jiaping Guo, Yameng Wang, Shanshan Niu, Hongping Li, Yongmei Tian, Songcheng Yu, Fei Yu, Yongjun Wu, Li-E Liu
1804 related Products with: Highly Sensitive Fluorescence-Linked Immunosorbent Assay for the Determination of Human IgG in Serum Using Quantum Dot Nanobeads and Magnetic FeO Nanospheres.4 Arrays/Slide4 Membranes/Box1 kit100 TESTS4 Arrays/Slide4 Membranes/Box4 Membranes/Box4 Membranes/Box4 Arrays/Slide
No related Items
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
Schweiz Züri +41435006251
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
53 Iskar Str. 1191 Kokalyane, Sofia